Ombitasvir /Paritaprevir/Ritonavir Plus Ribavirin on HCV GT4

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The objective of the investigators was to delineate the efficacy and safety of Ombitasvir, paritaprevir with ritonavir (OBV/PTV/r) plus ribavirin (RBV) on chronic HCV GT4 Egyptian naïve patients
Epistemonikos ID: 16128e6d3b039ebaefae65a8ae28536b082aaa0a
First added on: May 07, 2024